TOP
Nav Bar
  1. General Info
  2. Source Info
  3. Effects Info
  4. Reference
Phytochemical Details
01. General Information
Name Schisandrin B
PubChem CID 108130
Molecular Weight 400.5g/mol
Synonyms

(+--)-gamma-schizandrin, (-)-gomisin N, Benzo(3,4)cycloocta(1,2-f)(1,3)benzodioxole, 5,6,7,8-tetrahydro-1,2,3,13-tetramethoxy-6,7-dimethyl-, (6R,7S,13aR)-, benzo(3,4)cycloocta(1,2-F)(1,3)benzodioxole, 5,6,7,8-tetrahydro-1,2,3,13-tetramethoxy-6,7-dimethyl-, (6R,7S,13AS)-, gamma-schizandrin, gomisin N, schisandrin B, schizandrin B, wuweizisu b

Formula C₂₃H₂₈O₆
SMILES CC1CC2=CC3=C(C(=C2C4=C(C(=C(C=C4CC1C)OC)OC)OC)OC)OCO3
InChI 1S/C23H28O6/c1-12-7-14-9-16(24-3)20(25-4)22(26-5)18(14)19-15(8-13(12)2)10-17-21(23(19)27-6)29-11-28-17/h9-10,12-13H,7-8,11H2,1-6H3
InChIKey RTZKSTLPRTWFEV-UHFFFAOYSA-N
CAS Number 61281-37-6
ChEMBL ID CHEMBL479488
Structure 2D-img
Download
2D MOL 3D MOL
02. Source Information of Phytochemical
Schisandra chinensis Warm
Chineses Pinyin WuWeiZi
Use Part Fruit
Habitat HeiLongJiang, JiLin, LiaoNing, BeiJing, TianJin, HeBei, ShanXi, NeiMengGu, HuBei, HuNan, JiangXi, SiChuan
Flavor Sour; Sweet
Meridian Tropism Lung; Heart; Kidney
Species
>Kingdom: Viridiplantae
 -->Phylum: Streptophyta
  -->Class: Equisetopsida
   -->Order: Austrobaileyales
    -->Family: Schisandraceae
     -->Genus: Schisandra
      -->Species: Schisandra chinensis
03. Combinatorial Therapeutic Effect(s)
Synergistic Effect
Hide/Show
Drug(s) whose toxicity can be decreased by this phytochemical
Hide/Show
Combination Pair ID: 333
Pair Name Schisandrin B, Panitumumab
Partner Name Panitumumab
Disease Info [ICD-11: 2B91] Colorectal cancer Investigative
Biological Phenomena Induction-->Autophagy
Gene Regulation Down-regulation Expression BCL2 hsa596
Down-regulation Expression BECN1 hsa8678
Up-regulation Activity CASP3 hsa836
Down-regulation Expression MAP1LC3B hsa81631
In Vitro Model Caco-2 Colon adenocarcinoma Homo sapiens (Human) CVCL_0025
HCT 116 Colon carcinoma Homo sapiens (Human) CVCL_0291
HT-29 Colon adenocarcinoma Homo sapiens (Human) CVCL_0320
Result This novel combination therapy against CRC, allows the reduction of panitumumab dose to guard against its adverse effects.
04. Reference
No. Title Href
1 The potential effect of Schisandrin-B combination with panitumumab in wild-type and mutant colorectal cancer cell lines: Role of apoptosis and autophagy. J Biochem Mol Toxicol. 2023 May;37(5):e23324. doi: 10.1002/jbt.23324. Click
It has been 48220 visits since 2024.08
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang
TOP